Pediatrix Medical Group Statistics
Total Valuation
MD has a market cap or net worth of $1.12 billion. The enterprise value is $1.56 billion.
Important Dates
The next estimated earnings date is Tuesday, August 5, 2025, before market open.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MD has 84.21 million shares outstanding. The number of shares has increased by 1.55% in one year.
| Current Share Class | 84.21M |
| Shares Outstanding | 84.21M |
| Shares Change (YoY) | +1.55% |
| Shares Change (QoQ) | +0.32% |
| Owned by Insiders (%) | 1.21% |
| Owned by Institutions (%) | 90.52% |
| Float | 83.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 8.08 |
| PS Ratio | 0.57 |
| Forward PS | 0.58 |
| PB Ratio | 1.43 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 5.79 |
| P/OCF Ratio | 5.25 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 6.93, with an EV/FCF ratio of 8.03.
| EV / Earnings | n/a |
| EV / Sales | 0.79 |
| EV / EBITDA | 6.93 |
| EV / EBIT | 7.88 |
| EV / FCF | 8.03 |
Financial Position
The company has a current ratio of 1.81, with a Debt / Equity ratio of 0.83.
| Current Ratio | 1.81 |
| Quick Ratio | 1.74 |
| Debt / Equity | 0.83 |
| Debt / EBITDA | 2.57 |
| Debt / FCF | 3.37 |
| Interest Coverage | 5.04 |
Financial Efficiency
Return on equity (ROE) is -10.01% and return on invested capital (ROIC) is 8.04%.
| Return on Equity (ROE) | -10.01% |
| Return on Assets (ROA) | 5.95% |
| Return on Invested Capital (ROIC) | 8.04% |
| Return on Capital Employed (ROCE) | 11.50% |
| Revenue Per Employee | $479,655 |
| Profits Per Employee | -$19,992 |
| Employee Count | 4,120 |
| Asset Turnover | 0.95 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MD has paid $1.29 million in taxes.
| Income Tax | 1.29M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +77.47% in the last 52 weeks. The beta is 1.27, so MD's price volatility has been higher than the market average.
| Beta (5Y) | 1.27 |
| 52-Week Price Change | +77.47% |
| 50-Day Moving Average | 13.69 |
| 200-Day Moving Average | 13.58 |
| Relative Strength Index (RSI) | 39.39 |
| Average Volume (20 Days) | 980,197 |
Short Selling Information
The latest short interest is 1.74 million, so 2.06% of the outstanding shares have been sold short.
| Short Interest | 1.74M |
| Short Previous Month | 1.95M |
| Short % of Shares Out | 2.06% |
| Short % of Float | 2.09% |
| Short Ratio (days to cover) | 1.36 |
Income Statement
In the last 12 months, MD had revenue of $1.98 billion and -$82.37 million in losses. Loss per share was -$0.99.
| Revenue | 1.98B |
| Gross Profit | 462.11M |
| Operating Income | 198.02M |
| Pretax Income | -267.92M |
| Net Income | -82.37M |
| EBITDA | 225.27M |
| EBIT | 198.02M |
| Loss Per Share | -$0.99 |
Full Income StatementBalance Sheet
The company has $219.18 million in cash and $655.32 million in debt, giving a net cash position of -$436.14 million or -$5.18 per share.
| Cash & Cash Equivalents | 219.18M |
| Total Debt | 655.32M |
| Net Cash | -436.14M |
| Net Cash Per Share | -$5.18 |
| Equity (Book Value) | 789.19M |
| Book Value Per Share | 9.38 |
| Working Capital | 220.62M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $214.34 million and capital expenditures -$20.01 million, giving a free cash flow of $194.33 million.
| Operating Cash Flow | 214.34M |
| Capital Expenditures | -20.01M |
| Free Cash Flow | 194.33M |
| FCF Per Share | $2.31 |
Full Cash Flow StatementMargins
Gross margin is 23.38%, with operating and profit margins of 10.02% and -4.17%.
| Gross Margin | 23.38% |
| Operating Margin | 10.02% |
| Pretax Margin | -4.10% |
| Profit Margin | -4.17% |
| EBITDA Margin | 11.40% |
| EBIT Margin | 10.02% |
| FCF Margin | 9.83% |
Dividends & Yields
MD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.55% |
| Shareholder Yield | -1.55% |
| Earnings Yield | -7.32% |
| FCF Yield | 17.27% |
Dividend DetailsAnalyst Forecast
The average price target for MD is $16.67, which is 24.87% higher than the current price. The consensus rating is "Buy".
| Price Target | $16.67 |
| Price Target Difference | 24.87% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 2.68% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 20, 2013. It was a forward split with a ratio of 2:1.
| Last Split Date | Dec 20, 2013 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
MD has an Altman Z-Score of 1.77 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.77 |
| Piotroski F-Score | 7 |